Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary

A new therapeutic class of oral agents firstly used for the treatment of type 2 diabetes mellitus is represented by gliflozines or sodium-glucose co-transporter 2 (SGLT2) inhibitors. SGLT2 inhibitors might be effective alone or in combination with any other drugs. This therapeutic class currently in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mascolo, Annamaria, Di Napoli, Raffaella, Balzano, Nunzia, Cappetta, Donato, Urbanek, Konrad, De Angelis, Antonella, Scisciola, Lucia, Di Meo, Irene, Sullo, Maria Giuseppa, Rafaniello, Concetta, Sportiello, Liberata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532622/
https://www.ncbi.nlm.nih.gov/pubmed/36211584
http://dx.doi.org/10.3389/fcvm.2022.1010693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532622/
https://www.ncbi.nlm.nih.gov/pubmed/36211584
http://dx.doi.org/10.3389/fcvm.2022.1010693

Ejemplares similares